Endostatin in Concurrent Chemoradiotherapy of head and neck cancer: A Randomized Controlled Prospective Study

Trial Profile

Endostatin in Concurrent Chemoradiotherapy of head and neck cancer: A Randomized Controlled Prospective Study

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jul 2014

At a glance

  • Drugs Endostatin (Primary) ; Antineoplastics
  • Indications Head and neck cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Planned initiation date (1 Jan 2009) added as reported by Chinese Clinical Trial Register record.
    • 21 May 2012 Planned End Date (31 Jan 2019) added as reported by Chinese Clinical Trial Register record.
    • 05 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top